11Jul 2022
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

The study assesses the magnitude and short-term durability of neutralizing antibodies after homologous and heterologous boosting with mRNA and Ad26.COV2.S vaccines. All prime-boost combinations substantially increase the neutralization titers to Omicron. However, the elevated titers declined rapidly within two months from the peak response compared with boosted titers against the prototypic D614G variant. In addition, Omicron sublineages BA.1, BA.2, and BA.3 but modestly reduced neutralizing activity against BA.2.12.1 and BA.4/BA.5 compared with BA.1. These results have implications for boosting requirements to protect against Omicron and future variants of SARS-CoV-2.

  • #family health

Like

Save

Share